The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...
PERFORMING effective risk assessments can be a difficult art to master. The very phrase—“compliance risk assessment”—can encompass a wide range of risks: anti-bribery, whistleblower retaliation, data ...